InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

- Current share price for ACL : $2.700

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$504 Update - Notification of buy-back - ACL 24 Feb 2026 9:31AM $2.210 $2.700 risen by 22.17%
$504 Update - Notification of buy-back - ACL 23 Feb 2026 9:34AM $2.260 $2.700 risen by 19.47%
$504 Change of Director's Interest Notice - S Butler 20 Feb 2026 3:56PM $2.270 $2.700 risen by 18.94%
$504 Update - Notification of buy-back - ACL 20 Feb 2026 9:19AM $2.200 $2.700 risen by 22.73%
$504 Update - Notification of buy-back - ACL 19 Feb 2026 9:10AM $2.150 $2.700 risen by 25.58%
$504 Update - Notification of buy-back - ACL 18 Feb 2026 8:58AM $2.200 $2.700 risen by 22.73%
$504 CEO contract update 16 Feb 2026 9:22AM $2.420 $2.700 risen by 11.57%
$504 Dividend/Distribution - ACL 16 Feb 2026 8:14AM $2.420 $2.700 risen by 11.57%
$504 ACL 1H26 financial results investor presentation 16 Feb 2026 8:10AM $2.420 $2.700 risen by 11.57%
$504 Appendix 4D and 1H26 financial reports 16 Feb 2026 8:10AM $2.420 $2.700 risen by 11.57%
$504 1H26 results - investor webinar 30 Jan 2026 9:47AM $2.690 $2.700 risen by 0.37%
$504 Ceasing to be a substantial holder 23 Jan 2026 12:12PM $2.645 $2.700 risen by 2.08%
$504 Becoming a substantial holder 19 Jan 2026 3:45PM $2.535 $2.700 risen by 6.51%
$504 Ceasing to be a substantial shareholder from AEF 19 Jan 2026 3:13PM $2.535 $2.700 risen by 6.51%
$504 Change in substantial holding from AEF 12 Jan 2026 10:52AM $2.725 $2.700 fallen by 0.92%
$504 Notification of cessation of securities - ACL 29 Dec 2025 8:13AM $2.690 $2.700 risen by 0.37%
$504 Notification of cessation of securities - ACL 23 Dec 2025 2:40PM $2.705 $2.700 fallen by 0.18%
$504 Update - Notification of buy-back - ACL 19 Dec 2025 11:30AM $2.665 $2.700 risen by 1.31%
$504 Update - Notification of buy-back - ACL 18 Dec 2025 9:23AM $2.800 $2.700 fallen by 3.57%
$504 Update - Notification of buy-back - ACL 17 Dec 2025 9:12AM $2.780 $2.700 fallen by 2.88%
$504 Update - Notification of buy-back - ACL 16 Dec 2025 9:12AM $2.800 $2.700 fallen by 3.57%
$504 Notification of cessation of securities - ACL 15 Dec 2025 11:34AM $2.830 $2.700 fallen by 4.59%
$504 Notification regarding unquoted securities - ACL 15 Dec 2025 9:48AM $2.820 $2.700 fallen by 4.26%
$504 Notification of cessation of securities - ACL 15 Dec 2025 9:37AM $2.820 $2.700 fallen by 4.26%
$504 Update - Notification of buy-back - ACL 15 Dec 2025 9:27AM $2.820 $2.700 fallen by 4.26%

101 - 125 of 1008 results

Page 5 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.